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Patients with Lynch Syndrome are at high risk for developing a variety of cancers including cancers of the colon or
rectum, small bowel, stomach, uterus, renal pelvis, ureter, biliary tract, ovaries, brain and pancreas (N Engl J Med
348: 919-32, 2003; Gut 57:1097-101, 2008; NCCN, Inc Guideline. Ft. Washington, PA. Online Version 2.2014). Lack of
MLH-1 and MSH-2 expression commonly result from germline mutations in this inherited cancer syndrome. Here,
we report the case of a patient with a molecularly confirmed germline mutation in MLH-1 along with a colon
cancer showing lack of expression of MLH-1 as well as a squamous cell cancer of the skin from the abdominal
wall also demonstrating lack of expression of MLH-1. This case appears to represent the second case report of a
squamous cell skin cancer apparently due to the Lynch Syndrome and further supports a proposed relationship
between Lynch Syndrome and these tumors.
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Background
Lynch Syndrome is the most common inherited colon
cancer syndrome and also is associated with an increased
risk for patients developing cancers of other tissue origin.
It has only once been reportedly associated with squamous
cell skin cancer.
Case presentation
A 54-year-old man underwent a right hemicolectomy on
February 10, 2011 and the pathology revealed a T4b
(14 cm and invading the pericolic fat), N1a (1 of 31 lymph
nodes involved with malignancy) M0 adenocarcinoma of
the colon. There was no family history of colon or other
gastrointestinal malignancies. CT scanning showed no
radiographic evidence of distant disease. He received
standard adjuvant chemotherapy with 12 doses of modi-
fied FOLFOX-6 chemotherapy (5-fluorouracil, leucovorin
and oxaliplatin) and has had no recurrence to date.
The malignancy demonstrated loss of MLH-1 expres-
sion and no BRAF mutation was identified (wild-type
(WT)BRAF). In January 2013, a routine follow-up ab-
dominal MRI showed a new 1.8 × 2.2 × 2.3 hyperintense
mass within the soft tissue on the left abdominal wall,
just above the umbilicus. The mass was removed and
identified as a “squamous cell carcinoma, moderately dif-
ferentiated, invasive (3.7 cm)”, with no tumor present at
peripheral or deep margins. Immunohistochemical (IHC)
staining showed loss of expression of MLH-1 and PMS-
2. The pathologist also performed IHC staining of the pa-
tient’s colonic adenocarcinoma which also showed “loss
of MLH-1 expression within the tumor cells”. Normal
controls were provided for both the colon cancer and
squamous cell skin cancer as part of the IHC staining
done.
The patient was seen by the medical genetics service
and germline analysis revealed that the patient’s germline
harbored a mutation in MLH-1, specifically the 1772del4
mutation. PCR-based full MLH-1 sequence and rearrange-
ment analysis was performed using colaris testing for full
sequence analysis (Myriad Genetics, Salt Lake City, UT).
This confirmed a diagnosis of the patient having the
Lynch Syndrome.
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Conclusions
The Lynch Syndrome is the most common inherited
syndrome predisposing patients to developing colon cancer.
The inherited syndrome is an autosomal dominant disorder
characterized by a germline mutation in one of several dif-
ferent mismatch repair genes (most commonly MLH-1,
MSH-2, MSH-6 or PMS-2). Germline mutations in MLH-1
comprise 32 % of cases of the Lynch Syndrome and result
in tumors lacking MLH-1 expression, as seen in our
patient’s colon cancer [1–3]. For those with germline
mutations in MLH-1, lifetime risks of cancers include
colon (40–80 %), endometrial (25–60 %), stomach (1–
13 %), ovary (4–24 %), hepatobiliary (1.4–4 %), urinary
tract (1–4 %), small bowel (3–6 %), brain (1–3 %),
pancreas (1–6 %) and sebaceous neoplasms (1–9 %)
[3]. Lack of expression of MLH-1 by IHC can also
result from a somatic cell mutation in BRAF. However,
this patient’s colon cancer showed WT BRAF.
Our patient had two invasive malignancies, both dem-
onstrating lack of MLH-1 expression and genetic testing
verified a germline mutation in the MLH-1 gene, confirm-
ing a molecular diagnosis of the Lynch Syndrome. Spor-
adic squamous cell skin cancers have not been studied
extensively for MLH-1 expression; one small series sug-
gests these tumors infrequently lack MLH-1 expression
[4]. Thus, it remains possible that this patient’s skin cancer
was sporadic . However, given the lack of expression of
MLH-1 in the colon cancer and the corresponding
germline mutation, it would seem far more likely that
this patient’s squamous cell carcinoma was related to
the Lynch syndrome. One other case of true squamous cell
cancer of the skin in a patient with the Lynch Syndrome
has been reported [5].
Because squamous cell skin cancer is relatively common,
considering the possibility that it is related to the Lynch
Syndrome in a particular patient should probably be
reserved for patients highly suspected of having Lynch
Syndrome or those with known Lynch Syndrome. This
second report of a patient with the Lynch Syndrome
and a squamous cell skin cancer lacking MLH-1 ex-
pression supports the conclusions of the authors of the
first case report that, although rare, inheritance of a
germline mutation in MLH-1 might also be considered
a risk factor for developing squamous cell skin cancer.
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